WHITMAN BURKE W 4
4 · AMICUS THERAPEUTICS, INC. · Filed Oct 4, 2021
Insider Transaction Report
Form 4
WHITMAN BURKE W
Director
Transactions
- Purchase
Common Stock
2021-10-01$9.56/sh+1,500$14,346→ 63,582 total
Footnotes (2)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.45 to $9.58. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.